Obesity-driven Cardiovascular Risk: Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists
Obesity is now a major global public health concern and a recognised risk factor for Cardiovascular Disease (CVD), the leading cause of morbidity and mortality worldwide. Chronic lowgrade inflammation, oxidative stress, insulin resistance, dyslipidemia, and endothelial dysfunction are promoted by excessive adiposit...